2022
DOI: 10.2217/fon-2021-1125
|View full text |Cite
|
Sign up to set email alerts
|

Radiomics of Dual-Energy Computed Tomography for Predicting Progression-Free Survival in Patients with Early Glottic Cancer

Abstract: Aim: This study aimed to predict progression-free survival (PFS) in patients with early glottic cancer using radiomic features on dual-energy computed tomography iodine maps. Methods: Radiomic features were extracted from arterial and venous phase iodine maps, and radiomic risk scores were determined by univariate Cox proportional hazards regression analysis and least absolute shrinkage and selection operator regression with tenfold cross-validation. The Kaplan–Meier method was used to evaluate the association… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 38 publications
1
0
0
Order By: Relevance
“…The small sample size makes it difficult to further stratify the subgroups to explore the relationship between site and outcomes. A previous study proved that radiomic features are an independent prognostic biomarker for LC (31), which agrees with our results.…”
Section: B Asupporting
confidence: 93%
“…The small sample size makes it difficult to further stratify the subgroups to explore the relationship between site and outcomes. A previous study proved that radiomic features are an independent prognostic biomarker for LC (31), which agrees with our results.…”
Section: B Asupporting
confidence: 93%
“…Despite MRI being the recommended imaging technique for the pelvic region, pre-surgical cancer staging is performed using CT scans worldwide due to their wider distribution and faster acquisition times. So far, CT-based radiomics coupled with machine learning (ML) models have demonstrated promising results in predicting the progression-free survival of other tumor types [ 19 ] including small cell lung cancer [ 20 ], esophageal cancer [ 21 ], glottic cancer [ 22 ] and gastric cancer [ 23 ]. However, such analyses have not been carried out yet for EC.…”
Section: Introductionmentioning
confidence: 99%